BIO
Bio-Rad Laboratories
Earnings and EPS analysis
- Stocks
- Healthcare
- NYSE: BIO
- Earnings
EPS in 2026 (TTM): $8.05
Last Report Period Date: Jun 30, 2026
As of October this year, based on Bio-Rad Laboratories's most recent financial report, the company's trailing twelve months EPS is $8.05. During 2025, BIO reported a per-share earnings of $27.87, which shows a rise compared to the EPS of -$65.36 recorded in 2024. Bio-Rad Laboratories's EPS for the quarterly period ending on Jun 30, 2026 came in at $13.89.
BIO earnings history
The yearly earnings per share during 2025 was $27.87, a rise of 142.6% compared to -$65.36 recorded in 2024. Over the quarter ending Jun 30, 2026, the earnings per share came in at $13.89, reflecting a 19% increase compared to the same quarter a year earlier. As of June 2026, the TTM EPS is $8.05. During 2024, the annual earnings per share was -$65.36, representing a decrease of 199.5% compared to 2023.
BIO EPS vs price chart
BIO EPS growth history
Bio-Rad Laboratories has recorded a growth in earnings per share of 19% over the past 12 months (YoY, quarterly). Bio-Rad Laboratories had an average annual EPS growth of -26.3% in the last five years. When assessed over a ten-year period, BIO's average EPS annual growth was 22.2%.
BIO Earnings Waterfall
BIO Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| JNJ Johnson & Johnson | 29.33 | 90.6% | 17.7% | 14.8% |
| A Agilent Technologies Inc | 32.9 | 3.4% | 3.1% | 14.5% |
| TMO Thermo Fisher Scientific Inc | 35.17 | 7.2% | 0% | 2% |
| GE General Electric Company | 36.21 | 35.8% | 447.4% | 12.1% |
| DHR Danaher Corp | 37.89 | -4.9% | -19.7% | 0.4% |
| BIO Bio-Rad Laboratories Inc - Class A | 45.86 | 142.6% | N/A | -26.3% |
| BDX Becton Dickinson & Company | 53.25 | -0.9% | -0.6% | 16.2% |
| HBIO Harvard Bioscience Inc | N/A | -357.1% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.